BackRigel Pharmaceuticals Overview

Rigel Pharmaceuticals Total Revenue

Revenue analysis for RIGL.

Quarterly Revenue

$58.82M
↑ 10.28% YoY

As of Mar 2026

Annual Revenue (TTM)

$299.77M
↑ 47.61% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin